*ST Sihuan: First Quarter Report for 2026

SZSIApr 27 00:00 · Announcements

Sihuan's NG-350A Shows Promising Early Results in Rectal Cancer Trial

TipRanksApr 20 17:09

*ST Sihuan: 2025 Annual Report

SZSIApr 18 00:00 · Announcements

*ST Sihuan: Summary of the 2025 Annual Report

SZSIApr 18 00:00 · Announcements

Sihuan Bio reported revenue of 3.44 billion yuan in 2025, an increase of 69.22% year-on-year, with a net loss attributable to shareholders of 37.0923 million yuan. Gross margin rose to 37.30%.

The gross profit margin increased to 37.30%, with operating cash flow reaching 78.1172 million yuan, reflecting a significant improvement in collections.

lanjinger.comApr 17 23:23

Shuanghuan (000518.SZ): Application for removal of delisting risk warning on stock trading

Gelonghui, April 17 — *ST Sihuan (000518.SZ) announced that on April 16, 2026, Jiangsu Sihuan Bioengineering Co., Ltd. convened the 18th meeting of its 10th Board of Directors, during which the proposal 'Regarding the Application for Removal of Delisting Risk Warning on the Company’s Stock Trading' was deliberated and approved. The company submitted an application to the Shenzhen Stock Exchange on April 17, 2026, to remove the delisting risk warning on its stock trading.

Gelonghui FinanceApr 17 22:04